Cargando…
1099. CMV PCR Agreement between Blood and Dried Blood Spots in Infants with Congenital Cytomegalovirus Infection
BACKGROUND: Dried blood spot (DBS) PCR sensitivity for congenital cytomegalovirus (cCMV) screening ranges from 34% to 86%, but it is unclear whether a negative DBS PCR reflects an absence of CMV DNAemia or a technical limitation in viral detection by DBS PCR. The objective of this study was to deter...
Autores principales: | Kim, Juhyeong, Wang, Huanyu, Katherine Medoro, Alexandra, Pifer, Traci, Crisan, Rachelle, Leber, Amy, Flint, Kaitlyn, Powell, Sebastian, Sanchez, Pablo J, Shimamura, Masako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679089/ http://dx.doi.org/10.1093/ofid/ofad500.072 |
Ejemplares similares
-
1621. "False-Positive" Cytomegalovirus (CMV) Screening Tests in Neonates: A Real Dilemma!
por: Lewald, Zachery S, et al.
Publicado: (2023) -
2335. Newborn Dried Blood Spot for Retrospective Diagnosis of Congenital Cytomegalovirus (CMV) Infection: It’s Time for Universal Screening!
por: Medoro, Alexandra K, et al.
Publicado: (2019) -
1187. Neurodevelopmental Outcomes of Children with Congenital Cytomegalovirus (cCMV) Infection: Does Antiviral Treatment Matter?
por: Jia, Margaret R, et al.
Publicado: (2021) -
“Targeted” Screening for Cytomegalovirus (CMV)-Related Hearing Loss: It’s Time for Universal CMV Screening in the NICU!
por: Medoro, Alexandra, et al.
Publicado: (2017) -
1143. Late-Onset Hearing Loss and Antiviral Therapy for Congenital Cytomegalovirus Infection
por: Medoro, Alexandra K, et al.
Publicado: (2020)